Back to top

Analyst Blog

On May 27, shares of Aetna Inc. (AET - Analyst Report) hit a new 52-week high of $77.68 per share. The momentum in the share price was propelled by the company’s solid first quarter earnings following which it raised its 2014 earnings guidance.  

Aetna delivered positive earnings surprise in two of last four quarters with an average beat of 8.4%. The stock has gained 6.1% since the earnings release on April 24, and has surged 14.5% year to date, reflecting a much higher movement than 4.4% increase in S&P 500 stock level. Aetna has breezed past its ilk, including big players like UnitedHealth Group Inc. (UNH - Analyst Report) and Cigna Corp. (CI - Analyst Report) that have has risen 6.5% and 3.2% respectively, year to date.

The solid performance by Aetna was largely fueled by higher underwriting margins in the Health Care business and accretion from the Coventry acquisition.

Aetna is one of the biggest health insurances in the U.S. and has made considerable investments in products and technology, with an intention to extend its core health business and capitalize on exciting new consumer and provider opportunities emerging in the marketplace.

It is one of the players that is proactively seeking ways to counter the numerous challenges thrown by the Health Care Reform Act which has brought about structural changes in the industry.

Aetna’s Coventry acquisition is turning out more accretive than earlier estimated, and is contributing to overall earnings. Aetna is also making inroads into international markets which offer huge growth opportunities.

After a successful initial experience with the newly established Obamacare online exchanges, Aetna now plans to expand its presence to more states.

The company is also building on its Accountable Care Organization strategy to generate incremental revenues.

Aetna’s strong balance sheet with consistent cash flow generation and low leverage is yet another positive.

Aetna carries a Zacks Rank #3 (Hold). However, Select Medical Holdings Corporation (SEM - Snapshot Report) with a more favorable Zacks Rank #1 (Strong Buy) is worth considering.

Please login to Zacks.com or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research

Close

Are you a new Zacks Member or a visitor to Zacks.com?

Top Zacks Features

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
UTD THERAPE… UTHR 117.83 +28.51%
TRIQUINT SE… TQNT 20.67 +6.52%
VASCO DATA… VDSI 14.77 +4.68%
BANCO DO BR… BDORY 15.53 +3.95%
STRATTEC SE… STRT 80.24 +3.00%